Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients
Epigenetic modifications are involved in breast carcinogenesis. Identifying genes that are epigenetically silenced via methylation could select target patients for diagnostic as well as therapeutic potential. We assessed promoter methylation of breast cancer susceptibility gene 1 (BRCA1) and 17 Beta...
Saved in:
| Main Authors: | Marwa M. Hosny, Nagwan A. Sabek, Taghrid B. El-Abaseri, Fathalla M. Hassan, Sherif H. Farrag |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Breast Cancer |
| Online Access: | http://dx.doi.org/10.1155/2016/9545241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SNPs variety of 3-β-hydroxysteroid dehydrogenase 1 (HSD3B1) gene are related to prostate cancer in some Iraqi individuals
by: Zahraa Isam Jameel
Published: (2025-06-01) -
Deciphering 17-β-hydroxysteroid dehydrogenase 4: from molecular insights to cancer therapeutics
by: Meng-Bin Liao, et al.
Published: (2025-07-01) -
Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome.
by: Carmen J Marsit, et al.
Published: (2012-01-01) -
Daidzein-rich isoflavone aglycones inhibit 17β-hydroxysteroid dehydrogenase 1 and increase estrogen sulfotransferase in endometriosis
by: Yosuke Tarumi, et al.
Published: (2025-12-01) -
Two Faces of TGF-Beta1 in Breast Cancer
by: Joanna Magdalena Zarzynska
Published: (2014-01-01)